Objective Response Predicts Survival in Advanced Hepatocellular Carcinoma treated with Systemic Therapies-Reference-Cited by-同舟云学术

Objective Response Predicts Survival in Advanced Hepatocellular Carcinoma treated with Systemic Therapies

Published:2021-12-14 Issue: Volume: Page:clincanres.3135.2021
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Kudo Masatoshi,Montal Robert^ORCID,Finn Richard S.,Castet Florian^ORCID,Ueshima Kazuomi,Nishida Naoshi^ORCID,Haber Philipp K.^ORCID,Hu Youyou,Chiba Yasutaka,Schwartz Myron^ORCID,Meyer Tim^ORCID,Lencioni Riccardo,Llovet Josep M^ORCID

Funder

HHS | NIH | National Cancer Institute

U.S. Department of Defense

NIHR | UCLH Biomedical Research Centre

Samuel Waxman Cancer Research Foundation

Fundación Científica Asociación Española Contra el Cáncer

Government of Catalonia | Agència de Gestió d'Ajuts Universitaris i de Recerca

Ministerio de Sanidad, Servicios Sociales e Igualdad

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatocellular Carcinoma: The Evolving Role of Systemic Therapies as a Bridging Treatment to Liver Transplantation;Cancers;2024-05-30

2. Characterization of Tumor Responses in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib in the Phase 3 Randomized Trial: REFLECT;Liver Cancer;2024-02-26

3. Surrogacy of one-year survival for overall survival in advanced hepatocellular carcinoma;BMC Cancer;2024-02-23

4. The GRAPHS-CRAFITY score: a novel efficacy predictive tool for unresectable hepatocellular carcinoma treated with immunotherapy;La radiologia medica;2024-01-05

5. Efficacy of Adding Locoregional Therapy in Non-Complete Remission Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab: A Preliminary Study;Anticancer Research;2023-12-30